• Home

  • Company

  • Products

  • Technology

  • Market

  • Investor Relations

  • News/Publications

  • Contact

  • Blog

  • Jobs/Internships

  • More

       Company                       Product                               Technology                           Markets                                  Investor Relations

       Company Overveiw           G1A Test                                Overview                                Overview                                  Shareholder Website

       Management                   ACR Test                                 G1A Test                                G1A Test                                  Corporate Profile & Governance

       Advisory Board                SimplySure PT-INR Test             ACR Test                                ACR Test                           

                                                                                        SimplySure PT-INR Test            SimplySure PT-INR Test       

                                                                                        Intellectual Property                                                      

       

      Publications                                    Contact               

      Corporate Information Series                                  

      Scientific Reviews  

                                                                                                                                                                                  

                                  

     

     

     

     

     

    © 2016 by Epinex Diagnostics Inc

    ​

    Epinex-G1A-Glycated Albumin-Monthly Diabetes Test

    FOLLOW US:

    • w-facebook
    • Twitter Clean
    • White LinkedIn Icon

    MARKET-OVERVIEW

    Market Overview
    The Epinex G1A Test
    The Epinex ACR Test
    The Epinex SimplySure PT-INR Test

    OVERVIEW

    Our products will initially target the point-of-care (POC) and physician’s office laboratory (POL) market segments within the domestic and international in vitro diagnostics device market, with expansion predicted into retail pharmacy/over-the-counter (OTC), clinical labs, and Health Care Associations. Our customers will include physicians, hospitals, emergency rooms, wholesale distributors, and pharmacies.

     

    Market Strategy

    Our products have been designed to offer a clear-cut differentiation with currently available tests for monitoring diabetes, kidney function and coagulation.

    • Lower cost

    • User convenience

    • Value of information

    • Facilitation of doctor-patient feedback

    • Therapeutic intervention

       

       

       

       

       

       

       

       

       

    Back